Vertex Pharmaceuticals Inc. (VRTX) Social Stream



Vertex Pharmaceuticals Inc. (VRTX): $318.13

-3.24 (-1.01%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VRTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 381

in industry

VERTEX PHARMACEUTICALS INC (VRTX) Price Targets From Analysts

Use the tables below to see what analysts covering VERTEX PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 19 $331 $175 $262.5 $316.33 -17.02%
2021-11-19 20 $331 $175 $255 $316.33 -19.39%
2021-11-28 19 $331 $175 $252 $316.33 -20.34%
2021-12-02 19 $341 $175 $252.526 $316.33 -20.17%
2021-12-05 19 $341 $175 $253.315 $316.33 -19.92%
2021-12-09 20 $341 $175 $254.15 $316.33 -19.66%
2022-01-07 20 $341 $175 $255.65 $316.33 -19.18%
2022-01-10 19 $341 $201 $259.894 $316.33 -17.84%
2022-01-26 19 $341 $203 $264.578 $316.33 -16.36%
2022-01-28 19 $341 $203 $267.736 $316.33 -15.36%
2022-02-03 19 $341 $208 $268.21 $316.33 -15.21%
2022-03-14 18 $341 $208 $268.21 $316.33 -15.21%
2022-03-22 18 $341 $208 $268.421 $316.33 -15.15%
2022-03-31 17 $341 $208 $267.722 $316.33 -15.37%
2022-04-04 17 $350 $208 $270.222 $316.33 -14.58%
2022-04-05 17 $350 $208 $271.888 $316.33 -14.05%
2022-04-13 17 $350 $210 $275.421 $316.33 -12.93%
2022-04-17 16 $350 $210 $278.578 $316.33 -11.93%
2022-05-04 16 $350 $210 $280.631 $316.33 -11.29%
2022-05-06 18 $350 $210 $282.105 $316.33 -10.82%
2022-05-09 18 $350 $210 $283.736 $316.33 -10.3%
2022-05-22 19 $350 $210 $282.479 $316.33 -10.7%
2022-05-23 19 $350 $210 $282.8 $316.33 -10.6%
2022-06-03 19 $350 $210 $284.809 $316.33 -9.96%
2022-06-13 17 $350 $240 $288.473 $316.33 -8.81%
2022-07-26 19 $365 $240 $296.764 $316.33 -6.19%
2022-08-03 19 $365 $240 $298 $316.33 -5.79%
2022-08-05 20 $365 $240 $298 $316.33 -5.79%
2022-08-08 20 $365 $250 $301.526 $316.33 -4.68%
2022-08-14 20 $365 $250 $301.684 $316.33 -4.63%
2022-09-27 20 $365 $250 $303.368 $316.33 -4.1%
2022-10-12 20 $365 $250 $303.631 $316.33 -4.01%
2022-10-16 20 $365 $250 $303.894 $316.33 -3.93%
2022-10-21 20 $365 $250 $304.157 $316.33 -3.85%
2022-10-28 20 $365 $250 $304.578 $316.33 -3.72%
2022-10-31 20 $365 $250 $307 $316.33 -2.95%
2022-11-11 20 $365 $250 $311.578 $316.33 -1.5%
2022-11-18 20 $365 $250 $312.631 $316.33 -1.17%

The Trend in the Analyst Price Target


Over the past 14 months, VRTX's average price target has gone up $54.04.

VRTX reports an average of 8.05% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-04 16 350 210 280.631 273.70 2.53%
2022-08-14 20 365 250 301.684 294.52 2.43%
2022-09-10 20 365 250 303.368 292.11 3.85%
2022-10-21 20 365 250 304.157 300.00 1.39%
2022-10-31 20 365 250 307.000 312.00 -1.6%

VRTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.7 13 0 7 0 0 20

The Trend in the Broker Recommendations


Over the past 15 months, VRTX's average broker recommendation rating improved by 0.19.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VRTX as an investment opportunity.

  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, VERTEX PHARMACEUTICALS INC's average analyst price target is greater than 4284.77% of them.
  • VERTEX PHARMACEUTICALS INC's number of analysts covering the stock is higher than 4272.63% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, VERTEX PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 156.41% of them.
  • In terms of how VERTEX PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -1408.81% of that group.

In the Pharmaceutical Products industry, RPRX, RGNX, and HALO are the three stocks most similar to VERTEX PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Is VRTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8842 seconds.